EUVIMEDEUVIMED entdecken
Crossref

A plasmonic MNAzyme signal amplification strategy for quantification of miRNA-4739 breast cancer biomarker

Andrea L Larraga-Urdaz, Borja Moreira-Álvarez, Jorge Ruiz Encinar, José M Costa-Fernández, María Luisa Fernández-Sánchez

Analytica Chimica Acta · 2024

DOI: 10.1016/j.aca.2023.341999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024. Verfasst von Andrea L Larraga-Urdaz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical and Analytical Chemistry, University of Oviedo, Avda. Julián Clavería 8, Oviedo 33006, Spain. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Biosensing Techniques, Metal Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Ministerio de Economía y Competitividad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A major challenge in the 21st century is the development of point-of-care diagnostic tools capable to detect and quantify disease biomarkers in a straightforward, affordable, sensitive, and specific manner. The remarkable plasmonic properties of gold nanoparticles (AuNPs) have promoted their use for development of simple methodologies for nucleic acid detection in combination with a variety of oligonucleotides amplification techniques. Here, assemblies of AuNPs with Multicomponent Nucleic Acid enzymes (MNAzymes) has been successfully used in the design of a highly sensitive and simple bioassay for rapid spectroscopic detection and quantification of miRNA-4739 in blood samples. The miRNA selected is a doxorubicin chemoresistant biomarker in breast cancer which overexpression promotes the proliferation, progression, and survival of cancer cells. In this work, two alternatives experimental designs, based on use of MNAzymes and AuNPs, have been optimized and applied for sensitive miRNA-4739 quantification: one based on a traditional direct measurement of wavelength shift and a second non-conventional simple approach based on isolation and measurement of free nanoparticles absorbance. Improvement in sensitivity and, higher measurement accuracy and precision were achieved with the second approach. The developed bioassay provides a detection limit as low as 7 pmolL-1 for miRNA-4739 quantification and performed satisfactory selectivity and well practical applicability by analysis of the miRNA-4739 in blood, demonstrating that the proposed strategy is a promising and suitable spectroscopic method for breast cancer diagnosis thought liquid biopsy of circulating tumoral cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsBiosensing TechniquesMetal NanoparticlesNucleic AcidsHumansFemaleBiomarkers, TumorGoldLimit of DetectionNucleic Acid Amplification Techniques

Stichwörter der Autor:innen

BiomarkerGold nanoparticlesMulticomponent nucleic acid enzymesSignal-amplificationmiRNA

Substanzen

MicroRNAsBiomarkers, TumorGoldNucleic Acids

Autor:innen und Institutionen

  • Department of Physical and Analytical Chemistry, University of Oviedo, Avda. Julián Clavería 8, Oviedo 33006, Spain.
  • Department of Physical and Analytical Chemistry, University of Oviedo, Avda. Julián Clavería 8, Oviedo 33006, Spain. Electronic address: jcostafe@uniovi.es.
  • Department of Physical and Analytical Chemistry, University of Oviedo, Avda. Julián Clavería 8, Oviedo 33006, Spain. Electronic address: marisafs@uniovi.es.

Förderung

  • Ministerio de Economía y Competitividad

Zitieren

APA

Larraga-Urdaz, A. L., Moreira-Álvarez, B., Encinar, J. R., Costa-Fernández, J. M., & Fernández-Sánchez, M. L. (2024). A plasmonic MNAzyme signal amplification strategy for quantification of miRNA-4739 breast cancer biomarker. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341999

Vancouver

Larraga-Urdaz AL, Moreira-Álvarez B, Encinar JR, Costa-Fernández JM, Fernández-Sánchez ML. A plasmonic MNAzyme signal amplification strategy for quantification of miRNA-4739 breast cancer biomarker. Analytica Chimica Acta. 2024. doi:10.1016/j.aca.2023.341999

BibTeX
@article{LarragaUrdaz2024,
  author = {Larraga-Urdaz, Andrea L and Moreira-Álvarez, Borja and Encinar, Jorge Ruiz and Costa-Fernández, José M and Fernández-Sánchez, María Luisa},
  title = {A plasmonic MNAzyme signal amplification strategy for quantification of miRNA-4739 breast cancer biomarker},
  journal = {Analytica Chimica Acta},
  year = {2024},
  doi = {10.1016/j.aca.2023.341999}
}
Kostenlos starten →